Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Fungal Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00004689
What this trial is testing

Phase II Study of Amithiozone (Thiacetazone) for Patients With Mycobacterium Avium Complex Pulmonary Disease

Who this might be right for
Mycobacterium Avium-intracellulare Infection
National Jewish Health 50
Not applicableStudy completedNCT07354425
What this trial is testing

Pneumococcal Community-Acquired Pneumonia Requiring Hospitalization Among Colombian Adults

Who this might be right for
Community Acquired Pneumonia (CAP)Pneumococcal Pneumonia
Universidad de la Sabana 688
Large-scale testing (Phase 3)Study completedNCT00419068
What this trial is testing

Trial of Adjunctive Vitamin D in Tuberculosis Treatment

Who this might be right for
Tuberculosis, Pulmonary
Barts & The London NHS Trust 146
Not applicableStudy completedNCT04891120
What this trial is testing

Treadmill Stress Test With and Without Mask

Who this might be right for
Healthy
Université de Sherbrooke 35
Post-approval studies (Phase 4)UnknownNCT06476210
What this trial is testing

The Safety and Efficacy of BDL(Bedaquiline Plus Delamanid Plus Linezolid) Regimen in Subjects With Pulmonary Infection of Multi-drug Resistant Tuberculosis (MDR-TB) or Rifampicin-Resistant Tuberculosis (RR-TB)

Who this might be right for
Pulmonary Tuberculosis
Beijing Chest Hospital 45
Testing effectiveness (Phase 2)Study completedNCT00633191
What this trial is testing

Anti-pseudomonas IgY to Prevent Infections in Cystic Fibrosis

Who this might be right for
Cystic FibrosisInfectionPseudomonas Aeruginosa
Immunsystem AB 14
Not applicableLooking for participantsNCT07178860
What this trial is testing

Respiratory Health and Wellbeing Post Pulmonary Tuberculosis

Who this might be right for
Tuberculosis (TB)
Liverpool School of Tropical Medicine 50
Testing effectiveness (Phase 2)Study completedNCT00786305
What this trial is testing

Nebulized Ceftazidime and Amikacin in Ventilator Associated Pneumonia

Who this might be right for
Pneumonia
Groupe Hospitalier Pitie-Salpetriere 40
Not applicableStudy completedNCT00245427
What this trial is testing

Outcomes of Patients Not Responding to Antibiotics in the Community

Who this might be right for
SinusitisBronchitis, ChronicPneumonia, Bacterial
CPL Associates 200
Not applicableStudy completedNCT00676169
What this trial is testing

The EPIC Observational Study

Who this might be right for
Cystic Fibrosis
CF Therapeutics Development Network Coordinating Center 1,248
Not applicableStudy completedNCT07135622
What this trial is testing

Xpert MTB/RIF Ultra Trial

Who this might be right for
Tuberculosis (TB)Pulmonary TB
Nestani Tukvadze 778
Not applicableLooking for participantsNCT05756582
What this trial is testing

Prevalence of Latent Tuberculosis Infection in Health-care Workers and Students

Who this might be right for
TuberculosisTuberculosis, PulmonaryTuberculosis Infection+2 more
Eleonora Nucera 2,040
Large-scale testing (Phase 3)Study completedNCT02290327
What this trial is testing

Re-Evaluating the Inhibition of Stress Erosions: Gastrointestinal Bleeding Prophylaxis In ICU

Who this might be right for
Stress Ulcer Prophylaxis
McMaster University 91
Large-scale testing (Phase 3)Study completedNCT02342886
What this trial is testing

Shortening Treatment by Advancing Novel Drugs

Who this might be right for
Tuberculosis, Pulmonary, Drug SensitiveTuberculosis, Pulmonary, Multi Drug-resistant
Global Alliance for TB Drug Development 284
Testing effectiveness (Phase 2)Study completedNCT00341354
What this trial is testing

Coated Endotracheal Tube and Mucus Shaver to Prevent Hospital-Acquired Infections

Who this might be right for
Infection
National Heart, Lung, and Blood Institute (NHLBI) 24
Large-scale testing (Phase 3)WithdrawnNCT02134106
What this trial is testing

Randomized-controlled Trial (RCT) on Combination Antibiotic for Infections Caused by Gram-negative Bacteria

Who this might be right for
BacteremiaHealthcare-associated PneumoniaVentilator-associated Pneumonia
Tan Tock Seng Hospital
Not applicableLooking for participantsNCT00018044
What this trial is testing

Study of Mycobacterial Infections

Who this might be right for
Mycobacterium Infections
National Institute of Allergy and Infectious Diseases (NIAID) 1,000
Not applicableEnded earlyNCT00008216
What this trial is testing

Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
Adult Langerhans Cell HistiocytosisChildhood Langerhans Cell HistiocytosisLeukemia+4 more
Columbia University 48
Not applicableStudy completedNCT04985994
What this trial is testing

Potential Role of Microbiome in Tuberculosis

Who this might be right for
Tuberculosis
Khyber Medical University Peshawar 450
Testing effectiveness (Phase 2)Study completedNCT02273661
What this trial is testing

Evaluation of a Therapeutic Strategy Including Nebulised Liposomal Amphotericin B (Ambisome®) in Maintenance Treatment of Allergic Bronchopulmonary Aspergillosis (Cystic Fibrosis Excluded).

Who this might be right for
Allergic Bronchopulmonary Aspergillosis
Poitiers University Hospital 174
Next Page